Global Cord Blood Banking Services Market- Regional Analysis
Among region, North America is estimated to hold a dominant position in the global cord blood banking services market over the forecast period, owing to increasing launches of products. For instance, on April 19, 2023, Americord Registry LLC, a U.S.-based biotechnology company, announced U.S. Food and Drug Administration (FDA) approval of Gamida Cell product Omisirge, an innovative therapy that expands the number of cord blood stem cells used for treatment. This approval revolutionizes the field of regenerative medicine and highlights the increasing importance of cord blood banking.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients